Drug Type Genetically engineered subunit vaccine |
Synonyms SCT-1000, SCT1000 |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Ischemic Stroke | Phase 3 | CN | 31 Aug 2023 | |
Acute Ischemic Stroke | Phase 3 | CN | 31 Aug 2023 | |
Anus Neoplasms | Phase 3 | CN | 31 Aug 2023 | |
Anus Neoplasms | Phase 3 | CN | 31 Aug 2023 | |
Condylomata Acuminata | Phase 3 | CN | 31 Aug 2023 | |
Condylomata Acuminata | Phase 3 | CN | 31 Aug 2023 | |
Uterine Cervical Cancer | Phase 3 | CN | 31 Aug 2023 | |
Uterine Cervical Cancer | Phase 3 | CN | 31 Aug 2023 | |
Vaginal Neoplasms | Phase 3 | CN | 31 Aug 2023 | |
Vaginal Neoplasms | Phase 3 | CN | 31 Aug 2023 |